The ligands of translocator protein inhibit human Th1 responses and the rejection of murine skin allografts.
- Published in:
- Clinical Science, 2017, v. 131, n. 4, p. 297, doi. 10.1042/CS20160547
- By:
- Publication type:
- Article
Works matching IS 01435221 AND DT 2017 AND VI 131 AND IP 4
Results: 7
1
2
Turning up the heat against metabolic syndrome and non-alcoholic fatty liver disease.
- Published in:
- Clinical Science, 2017, v. 131, n. 4, p. 327, doi. 10.1042/CS20160855
- By:
- Publication type:
- Article
3
En route to precision medicine through the integration of biological sex into pharmacogenomics.
- Published in:
- Clinical Science, 2017, v. 131, n. 4, p. 329, doi. 10.1042/CS20160379
- By:
- Publication type:
- Article
4
Dual effects of fructose on ChREBP and FoxO1/3α are responsible for AldoB up-regulation and vascular remodelling.
- Published in:
- Clinical Science, 2017, v. 131, n. 4, p. 309, doi. 10.1042/CS20160251
- By:
- Publication type:
- Article
5
Defective adaptive thermogenesis contributes to metabolic syndrome and liver steatosis in obese mice.
- Published in:
- Clinical Science, 2017, v. 131, n. 4, p. 285, doi. 10.1042/CS20160469
- By:
- Publication type:
- Article
6
Contribution of innate immune cells to pathogenesis of severe influenza virus infection.
- Published in:
- Clinical Science, 2017, v. 131, n. 4, p. 269, doi. 10.1042/CS20160484
- By:
- Publication type:
- Article
7
The complexity of lipoprotein (a) lowering by PCSK9 monoclonal antibodies.
- Published in:
- Clinical Science, 2017, v. 131, n. 4, p. 261, doi. 10.1042/CS20160403
- By:
- Publication type:
- Article